Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 22 relevant Journals, 92 Conferences, 22 National symposiums are presently dedicated exclusively to nonischemic cardiomyopathy. and about 159 articles are being published on nonischemic cardiomyopathy.
Nonischemic cardiomyopathy is a vague term that does not describe underlying pathology. Nonischemic cardiomyopathy of the heart is reminiscent of the term “interstitial infiltrate” on a chest radiograph. Similar to that of interstitial lung disease, the differential diagnosis of nonischemic cardiomyopathy is lengthy. Historically, nonischemic cardiomyopathies have been described by changes in the morphology or function of the heart. An enlarged, thickened heart was termed “hypertrophic” cardiomyopathy and a thin-walled enlarged heart was termed “dilated” cardiomyopathy. The heart could also be stiff and unable to relax normally due to infiltration—termed “restrictive” cardiomyopathy as in amyloidosis (infiltration by amyloid protein) or sarcoidosis (granulomatous involvement of the heart).
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 morescientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance:
Non-Ischemic cardiomyopathy involves loss of elasticity of the heart walls that prevents the heart from adequately filling with blood prior to contracting. Except when caused by viral infections, cardiomyopathy develops slowly and may produce no symptoms until the later stages. The disorder is relatively rare, accounting for only 1 percent of heart diseases fatalities in the United States, although it is one of the more common causes of serious heart disease in younger people. Cardiomyopathy due to coronary disease is very common in the elderly. Depending upon the type of cardiomyopathy, treatment may include medications, implantable devices or, in severe cases, a heart transplant.
Cardiomyopathy the is a heart disease. The damaged heart does not pump blood correctly. The disease usually progresses, and patients develop life-threatening heart failure. People with cardiomyopathy are also more likely to have irregular heartbeats or arrhythmias.
There are two categories of cardiomyopathy: ischemic and non-ischemic. Ischemic cardiomyopathy is most common. It occurs when the heart is damaged from heart attacks due to coronary artery disease. Non-ischemic cardiomyopathy is less common. It includes types of cardiomyopathy that are not related to coronary artery disease.
There are three main types of non-ischemic cardiomyopathy:
• Dilated—Damaged heart muscles lead to an enlarged, floppy heart. The heart stretches as it tries to make up for a weakened ability to pump.
• Hypertrophic—Heart muscle fibers enlarge abnormally. The heart does not relax correctly between beats. The heart wall thickens, leaving less space for blood to fill the chambers, so less blood is pumped from the heart.
• Restrictive—Parts of the heart wall stiffen. Thickening often occurs due to abnormal tissue invading the heart.
Restrictive cardiomyopathy involves loss of elasticity of the heart walls that prevents the heart from adequately filling with blood prior to contracting. Except when caused by viral infections, cardiomyopathy develops slowly and may produce no symptoms until the later stages. The disorder is relatively rare, accounting for only 1 percent of heart disease fatalities in the United States, although it is one of the more common causes of serious heart disease in younger people. Cardiomyopathy due to coronary disease is very common in the elderly. Depending upon the type of cardiomyopathy, treatment may include medications, implantable devices or, in severe cases, a heart transplant.
Market Analysis:
Non-Ischemic cardiomyopathy can develop at any age but it is more common among people aged between 20 years and 60 years. According to American Society for Clinical Investigation about 25% - 50% of the total Non-Ischemic cardiomyopathy cases are genetically caused, owing to mutation in genes encoding for cytoskeleton, contractile, or other proteins in myocardial cells. In terms of market revenue (USD million) for the period 2012 to 2020. The report also provides the compounded annual growth rate (CAGR %) for each of these segments for the forecast period from 2014 to 2020, considering 2012 and 2013 as base years. Geographic regions analysed for this market include North America, Europe, Asia Pacific and Rest of the World. The North American market comprises the United States and Canada.
List of Best International Conferences:
1. 6th Clinical Cardiology Conference November 30-December 02, 2015 San Antonio, USA
2. 7th Cardiothoracic Conference March 29-30, 2016 Atlanta, USA
3. 8th Cardiologists Conference July 18-20, 2016 Berlin, Germany
4. Cardiac Nursing Conference May 5-7, 2016 Chicago, USA
5. 2nd Pediatric Cardiology Conference September 22-24, 2016, Las Vegas, USA
6. Transplantation Conference
7. 4th Healthcare Conference July 18-20, 2016 Brisbane, Australia
8. Healthcare Conference November 09-11, 2015 Dubai, UAE
9.
11. Healthcare Conference October 05-07, 2015 New Delhi, India
12. Hypertension Conference, Aug 4-6, 2016, Toronto, Canada
13. 10th Interventional Cardiology Conference, Sept 12-14, 2016, Berlin, Germany
14. Cardiovascular Imaging Conference, Nov 7-9, 2016, Istanbul, Turkey
15. Angiology Conference Dec 8-10, 2016,San Antonio, USA
16. Internal Medicine Conference, November 03-05, 2016 Baltimore, Maryland, USA
17. Anesthesia and Intensive Care conference September 12-14, 2016 Phoenix, Arizona, USA
18. 4th Surgery Conference October 05-07, 2015 Crowne Plaza, Dubai, UAE
19. 5th Surgery Conference October 06-08, 2016 Alicante, Spain
20. 2nd Pain Medicine Conference May 16-18, 2016 San Antonio, USA
21. Hospice and Palliative Care Conference August 31-September 02, 2015 Orlando, USA
22. 2nd Hospice and Palliative Care Conference August 25-27, 2016 Philadelphia, USA
23. Hypertrophic Cardiomyopathy: A Contemporary Treatable Disease - International Summit, September 27-29, 2015, Minneapolis, , USA
24. The 4th International Congress on Cardiac Problems in Pregnancy, 27 February-1 March,2016 Lavagas, USA
25. International Clinical Cardiovascular Genetics Conference 2016, 25-27 March 2016, Brisbane, Australia
26. Cardiac Development, Regeneration and Repair, April 3—7, 2016, Snowbird Resort, Snowbird, Utah, USA
27. Autophagy in Stress, Development & Disease, March 20-25, 2016, Ventura, CA
Relevant Society and Associations
1. European Society of Cardiology
2. Canadian Society of Echocardiography
3. Society of Thoracic surgeons
4. The American Society for Preventive Cardiology
5. Russian Society of Cardiology
6. European Society of Cardiology
7. Cardiological Society of India
8. ESC National Cardiac Societies
9. British Cardiovascular Society
10. AEPC Association for European Paediatric Cardiology
11. The International Society of Cardiology
12. Canadian Cardiovascular Society
13. American College of Cardiology
14. Coeliac Society of Ireland
15. Korean Society of Cardiology
16. Caribbean Cardiac Society
17. British Cardiovascular Intervention Society
18. Pediatric Interventional Cardiology Early Career Society
19. American Heart Association
20. World Heart Federation
Companies
1. Medtronic plc
2. Biosense Webster, Inc.
3. St. Jude Medical, Inc.
4. KARL STORZ GmbH & Co. KG
5. Medtronic plc
6. Abundant Home Care
7. Boston Scientific Corporation
8. Devicor Medical Products, Inc.
9. Endologix, Inc.
10. Ethicon, Inc.
11. Flexcell International Corporation
12. NovoStent Corporation
13. Seattle Urological Associates
14. Terumo Cardiovascular Systems Corporation
15. Vascular Pathways, Inc.
16. Cook Medical Incorporated
17. Medtronic plc
18. Nolato AB
19. Arterium Corporation
20. Aircraft Medical Limited
21. C. R. Bard, Inc.
22. CareFusion Corporation
23. Merit Medical Systems, Inc.
24. Siemens Healthcare
25. Hitachi Medical Corporation
This page will be updated regularly.
This page was last updated on April 20, 2024